<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03544008</url>
  </required_header>
  <id_info>
    <org_study_id>Axios AEs</org_study_id>
    <nct_id>NCT03544008</nct_id>
  </id_info>
  <brief_title>Multicenter Retrospective International Survey to Evaluate the Rate of AXIOS-related AEs in Endoscopic Transmural Drainage of Pancreatic Fluid Collections</brief_title>
  <official_title>Multicenter Retrospective International Survey to Evaluate the Rate of AXIOS-related AEs in Endoscopic Transmural Drainage of Pancreatic Fluid Collections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Clinico Humanitas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Clinico Humanitas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective study. Electronic chart review at respective centers will be the only&#xD;
      database used. No patient contact or additional procedures will be conducted.&#xD;
&#xD;
      The main objectives are:&#xD;
&#xD;
      A) To evaluate the use of AXIOS in Endoscopic transmural drainage of Pancreatic fluid&#xD;
      collections (PFC) in terms of clinical success and technical success.&#xD;
&#xD;
      B) To assess the rates, management, need for re-intervention, need for surgery, etiology and&#xD;
      characteristics of Pancreatic fluid collections (PFC) on the occurrence of AXIOS- related&#xD;
      related adverse events(AE).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective study. Electronic chart review at respective centers will be the only&#xD;
      database used. No patient contact or additional procedures will be conducted.&#xD;
&#xD;
      Data that will be recorded on review of electronic medical record database include:&#xD;
&#xD;
      I. Demographics (age, gender) II. Indication for procedure III. Diagnosis and findings&#xD;
      including radiologic findings IV. Prior endoscopy treatments V. Type and number of stents&#xD;
      used VI. Pancreatic fluid collection location and measurements VII. Procedure time VIII.&#xD;
      Technical success IX. Clinical success X. Adverse events XI. Management of adverse events&#xD;
      XII. Recurrence of pancreatic fluid collections XIII. Follow-up time&#xD;
&#xD;
      The above data will be collected and recorded in an excel sheet. The data collection will be&#xD;
      completely de-identified and password protected. The file will be emailed using an&#xD;
      institution email and encrypted. The password will be given in a separate email or by phone&#xD;
      call.&#xD;
&#xD;
      Inclusion:&#xD;
&#xD;
      All patients undergoing endoscopic management of pancreatic fluid collections between January&#xD;
      2011 to June 2017&#xD;
&#xD;
      Exclusion:&#xD;
&#xD;
      Age under 18&#xD;
&#xD;
      We will enroll 100 record between January 2011 to June 2017.&#xD;
&#xD;
      Time for collecting data:&#xD;
&#xD;
      1 month for data collection and 3 weeks for data analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2011</start_date>
  <completion_date type="Actual">December 2020</completion_date>
  <primary_completion_date type="Actual">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>The investigators will evaluate the use of AXIOS in Endoscopic transmural drainage of Pancreatic fluid collections (PFC)</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The investigators will assess the rates, management, need for re-intervention, need for surgery, etiology and characteristics of Pancreatic fluid collections (PFC) on the occurrence of AXIOS- related related adverse events(AE).</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Endoscopic Transmural Drainage of Pancreatic Fluid Collections</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>The use of AXIOS in Endoscopic transmural drainage</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing endoscopic management of pancreatic fluid collections between&#xD;
        January 2011 to June 2017&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients undergoing endoscopic management of pancreatic fluid collections between&#xD;
             January 2011 to June 2017&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age under 18&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>May 21, 2018</study_first_submitted>
  <study_first_submitted_qc>May 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2018</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

